Catherine J. Lee,
MD
Languages Spoken: English
Catherine J. Lee, MD is an Associate Professor of Medicine in the Division of Hematology/BMT at the Huntsman Cancer Center, University of Utah.
Dr. Catherine Lee's clinical expertise is in Blood and Marrow Transplantation (BMT) & Cellular Therapy. She specializes in autologous and allogeneic hematopoietic cell transplants for the treatment of malignant and benign hematologic diseases in adult patients. She also directs the clinical cellular therapy program and provides both standard-of-care cellular therapy treatments and those being tested in clinical trials. Furthermore, she leads the Chronic Graft-versus-Host Disease/Long-Term Follow-Up Program for patients who have received hematopoietic cell transplantation or other immune-cellular therapies. This program is designed to monitor the health and quality of life of patients after transplant, and also provides medical care specific to patients with chronic GVHD and late effects of hematopoietic cell transplantation or other cellular therapies. Her research portfolio includes design of clinical trials for chronic GVHD, implementation of interventions to improve access to high-quality BMT care, and optimizing the health of post-transplant/cellular therapy patients. She is also the local principal investigator for clinical trials surrounding CAR-T cell therapy, post-transplant maintenance strategies to prevent AML relapse, and novel conditioning regimens for MDS/AML. She is an active member of the American Society for Transplantation and Cellular Therapy (ASTCT), ASTCT Survivorship Special Interest Group, BMT CTN Steering Committee Member of the Toxicity and Supportive Care Committee, and the National Marrow Donor Program/Be The Match member of the Featured Trial Review Committee for the Jason Carter Clinical Trials Search and Support (CTSS).
Clinical Locations
801-585-2626
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Associate Professor (Clinical) |
| Academic Divisions | Hematology/BMT |
| Board Certification | American Board of Internal Medicine (Sub: Hematology) American Board of Internal Medicine (Sub: Medical Oncology) |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.9/ 5
Care provider's explanation of condition/problem
4.9/ 5
Care provider's effort to include me in decisions
4.9/ 5
Wait time at clinic
4.5/ 5
Care provider's concern for questions & worries
4.9/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
April 23, 2022
HUNTSMAN CANCER CENTER
Doctor Lee was so patient in answering my questions, and was up front in answering. Helped me leave feeling like I had someone looking out for me and would do her best to help.
UofU Patient
February 20, 2022
HUNTSMAN CANCER CENTER
Her explanations were easy to understand
UofU Patient
February 12, 2022
HUNTSMAN CANCER CENTER
Dr. Lee and everyone who works with her were very professional and very caring of their treatment for me.
UofU Patient
December 14, 2021
HUNTSMAN CANCER CENTER
I appreciate Jessica Coon's skill in doing my bone marrow biopsy.
UofU Patient
December 10, 2021
HUNTSMAN CANCER CENTER
Dr. Lee is an excellent provider - she answered all my questions, she was very attentive and explained things well, and I have a lot of trust in her. In addition, she is just very nice and warm - she definitely cares.
UofU Patient
December 06, 2020
HUNTSMAN CANCER CENTER
Dr. Lee is always very upfront about risks and concerns and is very thorough and her explanation as to the steps needed to be taken to get to transplant.
Catherine J. Lee, MD is an Associate Professor of Medicine in the Division of Hematology/BMT at the Huntsman Cancer Center, University of Utah.
Dr. Catherine Lee's clinical expertise is in Blood and Marrow Transplantation (BMT) & Cellular Therapy. She specializes in autologous and allogeneic hematopoietic cell transplants for the treatment of malignant and benign hematologic diseases in adult patients. She also directs the clinical cellular therapy program and provides both standard-of-care cellular therapy treatments and those being tested in clinical trials. Furthermore, she leads the Chronic Graft-versus-Host Disease/Long-Term Follow-Up Program for patients who have received hematopoietic cell transplantation or other immune-cellular therapies. This program is designed to monitor the health and quality of life of patients after transplant, and also provides medical care specific to patients with chronic GVHD and late effects of hematopoietic cell transplantation or other cellular therapies. Her research portfolio includes design of clinical trials for chronic GVHD, implementation of interventions to improve access to high-quality BMT care, and optimizing the health of post-transplant/cellular therapy patients. She is also the local principal investigator for clinical trials surrounding CAR-T cell therapy, post-transplant maintenance strategies to prevent AML relapse, and novel conditioning regimens for MDS/AML. She is an active member of the American Society for Transplantation and Cellular Therapy (ASTCT), ASTCT Survivorship Special Interest Group, BMT CTN Steering Committee Member of the Toxicity and Supportive Care Committee, and the National Marrow Donor Program/Be The Match member of the Featured Trial Review Committee for the Jason Carter Clinical Trials Search and Support (CTSS).
Academic Locations
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Associate Professor (Clinical) |
| Academic Divisions | Hematology/BMT |
| Board Certification | American Board of Internal Medicine (Sub: Hematology) American Board of Internal Medicine (Sub: Medical Oncology) |
Research Interests
- Telemedicine
- Cellular Therapy
- Allogeneic Stem Cell Transplantation
- Autologous Stem Cell Transplantation
- Long Term Complications and Survivorship Issues after Allogeneic Stem Cell Transplantation
- Biomarkers and New Treatments for Chronic Graft-Versus Host Disease
- Ancillary and Supportive Care for Chronic Graft-Versus-Host Disease
- Multidisciplinary Interventions and Patient Reported Outcomes in the Assessment of Response to Therapy in Chronic Graft-Versus Host Disease
Education History
| Fellowship | Stanford School of Medicine Blood and Marrow Transplantation Fellow, 2015 |
| Fellowship | University of Pittsburgh Cancer Institute Hematology-Oncology Fellow, 2014 |
| Fellowship | Fred Hutchinson/SCCA Blood and Marrow Transplant Program Blood and Marrow Transplantation Visiting Fellow, 2013 |
| Fellowship | Memorial Sloan Kettering Cancer Center Pain and Palliative Care Fellow, 2011 |
| Professional Medical | New York University School of Medicine Medicine M.D., 2007 |
| Undergraduate | Johns Hopkins University Public Health Medicine B.A., 2000 |
Selected Publications - Journal Articles
Journal Article
- Tao R, Chen Y, Kim S, Ocier K, Lloyd S, Poppe MM, Lee CJ, Glenn MJ, Smith KR, Fraser A, Deshmukh V, Newman MG, Snyder J, Rowe KG, Gaffney DK, Haaland B, Hashibe M (2022). Mental health disorders are more common in patients with Hodgkin lymphoma and may negatively impact overall survival. Cancer.
- Lee CJ, Wang T, Chen K, Arora M, Brazauskas R, Spellman SR, Kitko C, MacMillan ML, Pidala JA, Auletta JJ, Badawy SM, Bhatt N, Bhatt VR, Cahn JY, DeFilipp Z, Diaz MA, Farhadfar N, Gadalla S, Gale RP, Hashem H, Hashmi S, Hematti P, Hong S, Hossain NM, Inamoto Y, Lekakis LJ, Modi D, Patel S, Sharma A, Solomon S, Couriel DR (2022). Association of Chronic Graft-versus-Host Disease with Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy. Transplant Cell Ther, 28, 712.e1-712.e8.
- Himbert C, Hathaway CA, Daniels B, Salas K, Ashworth A, Gigic B, Lin T, Viskochil R, Kirchhoff AC, Grossman D, Ose J, Tward J, Scaife C, Figueiredo JC, Toriola AT, Beck A, Shibata D, Gonzalez BD, Matsen C, Christenson C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Schneider M, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM, Peoples AR (2022). Factors associated with changes in exercise behaviors during the COVID-19 pandemic. Cancer Causes Control, 33(7), 939-950.
- Peoples AR, Oswald LB, Ose J, Daniels B, Himbert C, Hathaway CA, Gigic B, Kirchhoff AC, Lin T, Grossman D, Tward J, Varghese TK Jr, Figueiredo JC, Toriola AT, Beck A, Scaife C, Shibata D, LaStayo P, Gonzalez B, Salas K, Ashworth A, Matsen C, Christenson C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Schneider M, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM (2022). Impact of the COVID-19 pandemic on rural and urban cancer patients' experiences, health behaviors, and perceptions. J Rural Health, 38, 886-899.
- Ocier K, Abdelaziz S, Kim S, Rowe K, Snyder J, Deshmukh VG, Newman M, Fraser A, Smith KR, Porucznik CA, Shoaf K, Stanford JB, Lee CJ, Hashibe M (2021). Age-Related Disease Risks in Younger versus Older B-Cell Non-Hodgkin's Lymphoma Survivors. Cancer Epidemiol Biomarkers Prev, 30(12), 2268-2277.
- Lee CJ, Pusic I, Savani BN (2021). Beyond ruxolitinib in steroid-refractory acute graft-versus-host disease. Br J Haematol, 195(3), 306-307.
- Bhatt NS, Brazauskas R, Salit RB, Syrjala K, Bo-Subait S, Tecca H, Badawy SM, Baker KS, Beitinjaneh A, Bejanyan N, Byrne M, Dias A, Farhadfar N, Freytes CO, Ganguly S, Hashmi S, Hayashi RJ, Hong S, Inamoto Y, Jamani K, Kasow KA, Khera N, Krem MM, Lazarus HM, Lee CJ, Lee S, Majhail NS, Malone AK, Marks DI, Mau LW, Mayo SJ, Muffly LS, Nathan S, Nishihori T, Page KM, Preussler J, Rangarajan HG, Rotz SJ, Salooja N, Savani BN, Schears R, Schechter-Finkelstein T, Schiller G, Shah AJ, Sharma A, Wang T, Wirk B, Battiwalla M, Schoemans H, Hamilton B, Buchbinder D, Phelan R, Shaw B (2021). Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States. Transplant Cell Ther, 27(8), 679.e1-679.e8.
- Ocier K, Abdelaziz S, Kim S, Rowe K, Snyder J, Deshmukh V, Newman M, Fraser A, Smith K, Porucznik CA, Shoaf K, Stanford JB, Lee CJ, Hashibe M (2021). Cardiovascular disease risks in younger versus older adult B-cell non-Hodgkin's lymphoma survivors. Cancer Med, 10(12), 4117-4126.
- Fennell K, Keller MA, Villa MA, Paccapelo C, Kucerakova M, Rosochova J, Clemente DosSantos C, Brackney L, Lee CJ, Metcalf R, Crovetti G, Barbieri M, Travali S, Barrotta G, Giuca G, Guerra LE, Ochoa-Garay G (2021). New ABO intron 1 variant alleles. Immunohematology, 37(4), 178-184.
- Im A, Rashidi A, Wang T, Hemmer M, MacMillan ML, Pidala J, Jagasia M, Pavletic S, Majhail NS, Weisdorf D, Abdel-Azim H, Agrawal V, Al-Homsi AS, Aljurf M, Askar M, Auletta JJ, Bashey A, Beitinjaneh A, Bhatt VR, Byrne M, Cahn JY, Cairo M, Castillo P, Cerny J, Chhabra S, Choe H, Ciurea S, Daly A, Perez MAD, Farhadfar N, Gadalla SM, Gale R, Ganguly S, Gergis U, Hanna R, Hematti P, Herzig R, Hildebrandt GC, Lad DP, Lee C, Lehmann L, Lekakis L, Kamble RT, Kharfan-Dabaja MA, Khandelwal P, Martino R, Murthy HS, Nishihori T, OBrien TA, Olsson RF, Patel SS, Perales MA, Prestidge T, Qayed M, Romee R, Schoemans H, Seo S, Sharma A, Solh M, Strair R, Teshima T, Urbano-Ispizua A, Van der Poel M, Vij R, Wagner JL, William B, Wirk B, Yared JA, Spellman SR, Arora M, Hamilton BK (2020). Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide. Biol Blood Marrow Transplant, 26(8), 1459-1468.
- Lee CJ, Kim S, Tecca HR, Bo-Subait S, Phelan R, Brazauskas R, Buchbinder D, Hamilton BK, Battiwalla M, Majhail NS, Lazarus HM, Shaw PJ, Marks DI, Litzow MR, Chhabra S, Inamoto Y, DeFilipp Z, Hildebrandt GC, Olsson RF, Kasow KA, Liesveld JL, Rotz SJ, Badawy SM, Bhatt NS, Yared JA, Page KM, Arellano ML, Kent M, Farhadfar N, Seo S, Hematti P, Freytes CO, Rov A, Ganguly S, Nathan S, Burns L, Shaw BE, Muffly LS (2019). Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia. Blood Adv, 4(6), 983-992.
- Barnes CA, Stout NL, Varghese TK Jr, Ulrich CM, Couriel DR, Lee CJ, Noren CS, LaStayo PC (2019). Clinically Integrated Physical Therapist Practice in Cancer Care: A New Comprehensive Approach. Phys Ther, 100(3), 543-553.
- Inamoto Y, Petriek I, Burns L, Chhabra S, DeFilipp Z, Hematti P, Rov A, Schears R, Shah A, Agrawal V, Ahmed A, Ahmed I, Ali A, Aljurf M, Alkhateeb H, Beitinjaneh A, Bhatt N, Buchbinder D, Byrne M, Callander N, Fahnehjelm K, Farhadfar N, Gale RP, Ganguly S, Hashmi S, Hildebrandt GC, Horn E, Jakubowski A, Kamble RT, Law J, Lee C, Nathan S, Penack O, Pingali R, Prasad P, Pulanic D, Rotz S, Shreenivas A, Steinberg A, Tabbara K, Tichelli A, Wirk B, Yared J, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Valds-Sanz N (2018). Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant, 25(5), e145-e154.
- Inamoto Y, Valds-Sanz N, Ogawa Y, Alves M, Berchicci L, Galvin J, Greinix H, Hale GA, Horn B, Kelly D, Liu H, Rowley S, Schoemans H, Shah A, Lupo Stanghellini MT, Agrawal V, Ahmed I, Ali A, Bhatt N, Byrne M, Chhabra S, DeFilipp Z, Fahnehjelm K, Farhadfar N, Horn E, Lee C, Nathan S, Penack O, Prasad P, Rotz S, Rov A, Yared J, Pavletic S, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Petriek I (2018). Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. Bone Marrow Transplant, 54(5), 662-673.
- Lee CJ, Savani BN, Mohty M, Gorin NC, Labopin M, Ruggeri A, Schmid C, Baron F, Esteve J, Giebel S, Ciceri F, Nagler A (2018). Post-remission strategies for the prevention of relapse following allogeneic hematopoietic cell transplantation for high-risk acute myeloid leukemia: expert review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant, 54(4), 519-530.
- Inamoto Y, Valds-Sanz N, Ogawa Y, Alves M, Berchicci L, Galvin J, Greinix H, Hale GA, Horn B, Kelly D, Liu H, Rowley S, Schoemans H, Shah A, Lupo Stanghellini MT, Agrawal V, Ahmed I, Ali A, Bhatt N, Byrne M, Chhabra S, DeFilipp Z, Fahnehjelm K, Farhadfar N, Horn E, Lee C, Nathan S, Penack O, Prasad P, Rotz S, Rov A, Yared J, Pavletic S, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Petriek I (2018). Ocular Graft-versus-Host Disease after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant, 25(2), e46-e54.
- Lee CJ, Labopin M, Beelen D, Finke J, Blaise D, Ganser A, Itl-Remes M, Chevallier P, Labussire-Wallet H1, Maertens J, Yakoub-Agha I, Bourhis JH, Mailhol A, Mohty M, Savani BN, Nagler A (2018). Comparative outcomes of myeloablative and reduced-intensity conditioning allogeneic hematopoietic cell transplantation for therapy-related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantation. Am J Hematol, 94(4), 431-438.
- Yoshihiro Inamoto, Nuria Valds-Sanz, Yoko Ogawa, Monica Alves, Luigi Berchicci, John Galvin, Hildegard Greinix, Gregory Hale, Biljana Horn, Debra Kelly, Hien Liu, Scott Rowley, Helene Schoemans, Ami Shah, Maria Stanghellini, Vaibhav Agrawal, Ibrahim Ahmed, Asim Ali, Neel Bhatt, Michael Byrne, Saurabh Chhabra, Zachariah DeFilipp, Kristina Fahnehjelm, Nosha Farhadfar, Erich Horn, Lee CJ, Sunita Nathan, Olaf Penack, Pinki Prasad, Seth Rotz, Alicia Rov, Jean Yared, Steven Pavletic, Grzegorz Basak, Minnoo Battiwalla, Rafael Duarte, Bipin Savani, Mary Flowers, Bronwen Shaw, and Igor Petricek (12/07/2018). Ocular graft-versus-host disease after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. Biol Blood Marrow Transplant, 25(2), e46-e54.
- Yoshihiro Inamoto, Igor Petricek, Linda Burns, Saurabh Chhabra, Zachariah DeFilipp, Peiman Hematti, Alicia Rov, Raquel Schears, Ami Shah, Vaibhav Agrawal, Aisha Al Khinji, Ibrahim Ahmed, Asim Ali, Mahmoud D Aljurf, Hassan Alkhateeb, Amer Beitinjaneh, Neel Bhatt, David Buchbinder, Michael Byrne, Natalie Callander, Kristina Fahnehjelm, Nosha Farhadfar, Robert Gale, Siddhartha Ganguly, Gerhard Hildebrandt, Erich Horn, Ann Jakubowski, Rammurti Kamble, Jason Law, Lee CJ, Sunita Nathan, Olaf Penack, Sai Pingali, Pinki Prasad, Drazen Pulanic, Seth Rotz, Aditya Shreenivas, Amir Steinberg, KF Tabbara, Andr Tichelli, Baldeep Wirk, Jean Yared, Grzegorz Basak, Minnoo Battiwalla, Rafael Duarte, BipinSavani, Mary Flowers, Bronwen Shaw, and Nuria Valds-Sanz (12/07/2018). Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. Bone Marrow Transplant, 54(5), 648-661.
- Radojcic V, Lee CJ, Couriel DR (2018). Multifaceted Burden of Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant, 24(9), 1774-1775.
- Lee CJ, Savani BN, Ljungman P (2018). Varicella Zoster Virus Reactivation in Adult Survivors of Hematopoietic Cell Transplantation: How Do We Best Protect Our Patients? Biol Blood Marrow Transplant, 24(9), 1783-1787.
- Lee CJ, Savani BN, Mohty M, Gorin NC, Labopin M, Ruggeri A, Schmid C, Baron F, Esteve J, Giebel S, Ciceri F, Nagler A (09/01/2018). Post-remission strategies for the prevention of relapse following allogeneic hematopoietic cell transplantation for high-risk acute myeloid leukemia: Expert review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant, 54(4), 519-530.
- Buchbinder D, Kelly DL, Duarte RF, Auletta JJ, Bhatt N, Byrne M, DeFilipp Z, Gabriel M, Mahindra A, Norkin M, Schoemans H, Shah AJ, Ahmed I, Atsuta Y, Basak GW, Beattie S, Bhella S, Bredeson C, Bunin N, Dalal J, Daly A, Gajewski J, Gale RP, Galvin J, Hamadani M, Hayashi RJ, Adekola K, Law J, Lee CJ, Liesveld J, Malone AK, Nagler A, Naik S, Nishihori T, Parsons SK, Scherwath A, Schofield HL, Soiffer R, Szer J, Twist I, Warwick AB, Wirk BM, Yi J, Battiwalla M, Flowers MDE, Savani B, Shaw BE (2018). Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT. Bone Marrow Transplant, 53(5), 535-555.
- Kelly DL, Buchbinder D, Duarte RF, Auletta JJ, Bhatt N, Byrne M, Gabriel M, Mahindra A, Norkin M, Schoemans H, Shah AJ, Ahmed I, Atsuta Y, Basak GW, Beattie S, Bhella S, Bredeson C, Bunin N, Dalal J, Daly A, Gajewski J, Gale RP, Galvin J, Hamadani M, Hayashi RJ, Adekola K, Law J, Lee CJ, Liesveld J, Malone AK, Nagler A, Naik S, Nishihori T, Parsons SK, Scherwath A, Schofield HL, Soiffer R, Szer J, Twist I, Warwick A, Wirk BM, Yi J, Battiwalla M, Flowers ME, Savani B, Shaw BE (2018). Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review From the Late Effects and Quality of Life Working Committee of the CIBMTR and Complications and Quality of Life Working Party of the EBMT. Biol Blood Marrow Transplant, 24(2), 228-241.
- Lee CJ, Savani BN, Mohty M, Labopin M, Ruggeri A, Schmid C, Baron F, Esteve J, Gorin NC, Giebel S, Ciceri F, Nagler A (2017). Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Haematologica, 102(11), 1810-1822.
- Lee CJ, Muffly LS (2017). Coordination of Care in Survivorship After Treatment of Hematological Malignancies-The Journey is Not Over Yet. Curr Hematol Malig Rep, 12(4), 317-323.
- Lee CJ, Muffly LS (2017). Coordination of Care in Survivorship After Treatment of Hematological Malignancies-The Journey is Not Over Yet. Curr Hematol Malig Rep, 12(4), 317-323.
- Lee CJ, Shiraz P, Muffly L (2017). Pharmacologic maintenance strategies following allogeneic hematopoietic cell transplantation for acute myeloid leukemia. Leuk Lymphoma, 58(3), 516-527.
- Couriel DR, Ricker H, Steinbach M, Lee CJ (2016). Neurologic Manifestations of Blood Dyscrasias. Hematol Oncol Clin North Am, 30(4), 723-31.
- Lee CJ, Ansell JE (2011). Direct thrombin inhibitors. Br J Clin Pharmacol, 72(4), 581-92.
- Lee CJ, Badhwar G, Ansell JE (2010). Oral IIa inhibitors. Hematol Oncol Clin North Am, 24(4), 739-53, ix.
- Kudla MJ, Timor-Tritsch IE, Hope JM, Monteagudo A, Popiolek D, Monda S, Lee CJ, Arslan AA (2008). Spherical tissue sampling in 3-dimensional power Doppler angiography: a new approach for evaluation of ovarian tumors. J Ultrasound Med, 27(3), 425-33.
- Gil OD, Lee C, Ariztia EV, Wang FQ, Smith PJ, Hope JM, Fishman DA (2008). Lysophosphatidic acid (LPA) promotes E-cadherin ectodomain shedding and OVCA429 cell invasion in an uPA-dependent manner. Gynecol Oncol, 108(2), 361-9.
- Lee CJ, Ariztia EV, Fishman DA (2007). Conventional and proteomic technologies for the detection of early stage malignancies: markers for ovarian cancer. Crit Rev Clin Lab Sci, 44(1), 87-114.
- Smicun Y, Reierstad S, Wang FQ, Lee C, Fishman DA (2006). S1P regulation of ovarian carcinoma invasiveness. Gynecol Oncol, 103(3), 952-9.
- Ariztia EV, Lee CJ, Gogoi R, Fishman DA (2006). The tumor microenvironment: key to early detection. Crit Rev Clin Lab Sci, 43(5-6), 393-425.
- Krishnan R, Pangilinan F, Lee C, Spencer F (2000). Saccharomyces cerevisiae BUB2 prevents mitotic exit in response to both spindle and kinetochore damage. Genetics, 156(2), 489-500.
Review
Book
- Lee CJ, Miller ES (2012). Deja Review: Obstetrics and Gynecology (2). New York, NY: McGraw-Hill Medical.
- Lee CJ, Miller ES (2008). Deja Review: Obstetrics and Gynecology (1). New York, NY: McGraw-Hill Medical.
Book Chapter
- Catherine J Lee, Mihkaila Wickline, and Mary ED Flowers (2021). Telemedicine in patient care of long-term transplant survivors. In Bipin Savani and André Tichelli (Eds.), Blood and Marrow Transplantation Long-Term Management: Prevention and Complications (2nd Edition). John Wiley & Sons Ltd.
- Nguyen A and Lee CJ (05/28/2018). Immunodeficiency-associated Lymphoproliferative Disorders. In Francis P. Worden, MD, Rami N. Khoriaty, MD, Kathleen A. Cooney, MD, MACP, and Michael W. Deininger, MD, PhD (Eds.), Hematology Board Review: Blueprint Study Guide and Q&A.
- Lee CJ (2006). Female Reproductive Tract. In Grisson RD, Song JW (Eds.), Deja Review: Histology & Medical Cell Biology (pp. 115-25). New York, NY: McGraw-Hill.
Conference Proceedings
- Lee CJ, Kane LP (2014). Expression and function of tim-3, a potential therapeutic target in acute myeloid leukemia. J Clin Oncol, 32(5s(suppl; abstr 7095)).
Letter
- Trunk AD, Shewan SK, Lee CJ, Parker CJ, Couriel DR (2022). Chronic graft-versus-host disease exacerbation after SARS-CoV-2 vaccination. [Letter to the editor]. Bone Marrow Transplant, 57, 502-503.
- Radojcic V, Pletneva M, Lee CJ, Ivcevic S, Sarantopoulos S, Couriel D (2021). Hedgehog blockade in steroid-refractory sclerotic chronic graft-versus-host disease. [Letter to the editor]. Br J Haematol, 195(2), e120-e122.
- Osborn JD, Cariello PF, Pena E, Lee CJ (2019). Nocardia thyroiditis after allogeneic hematopoietic cell transplantation. [Letter to the editor]. Leuk Lymphoma, 61(4), 983-986.
- Baron MK, Osborn JD, Tao R, Lee CJ (2019). Haploidentical hematopoietic cell transplantation for mycosis fungoides/Sezary syndrome. [Letter to the editor]. Leuk Lymphoma, 61(1), 231-233.
Abstract
- Michael T Byrne, Tony J Kurian, Dilan A Patel, Roni Tamari, Sanghee Hong, Haitham Abdelhakim, Victoria Klein, Patricio Rojas, Raksha Madhavan, Andrew Kent, Aaron C Logan, Catherine J Lee, Muhammad Husnain, Benjamin M Manning, Nicholas P Tschernia, Ajoy L Dias, Daniel Margalski, Benjamin Goldenson, Nathalie Byrne, Heidi Chen, Kseniya Petrova-Drus, Salyka M Sengsayadeth, Aaron M Goodman, Dianna S Howard, William A Wood, Saar Gill, Antonio M Jimenez, Jonathan A Gutman, Lohith Gowda, Leland Metheny, III, Bhavana Bhatnagar, Betty K Hamilton, Asmita Mishra, Michael R Savona (2021). Non-relapse Mortality in TP53-Mutated MDS/AML - Multi-Center Collaborative Study [Abstract]. 138 (Supplement 1), 2922.
- Lee CJ, Soyoung Kim, Heather R Tecca, Ruta Brazauskas, Minoo Battiwalla, David K Buchbinder, Mary E D Flowers, Rachel Phelan, Bronwen E Shaw and Lori S Muffly (01/14/2019). Impact of Myeloablative Total Body Irradiation Versus Chemotherapy on Late Effects and Survival Among Adolescent and Young Adult Survivors of Hematopoietic Cell Transplantation for Acute Leukemia: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis [Abstract]. Blood, 132.
- Derek K Chang, Jihye Park, Yuan Wan, Alison Fraser, Kerry Rowe, John Snyder, Vikrant Deshmukh, Michael Newman, Kimberly Herget, Ken Smith, Mia Hashibe and Lee CJ (01/14/2019). Increased Risk of Diabetes Mellitus Among Adult Survivors of B-Cell Non-Hodgkin Lymphoma [Abstract]. Blood, 132.
- Lee CJ, Myriam Labopin, Dietrich Beelen, Jrgen Finke, Didier Blaise, Arnold Ganser, Maija Itl-Remes, Patrice Chevallier, Hlne Labussire-Wallet, MD, PhD, Johan Maertens, Ibrahim Yakoub-Agha, Jean-Henri Bourhis, Audrey Mailhol, Mohamed Mohty, Bipin Savani, Arnon Nagler (12/01/2018). Superior Outcomes With Myeloablative Versus Reduced-Intensity Conditioning Allogeneic Hematopoetic Cell Transplantation for Secondary Acute Myeloid Leukemia with Prior Solid Tumor: An ALWP of EBMT Study [Abstract]. Bone Marrow Transplantation.
- Christopher Barnes, Nicole L Stout, Thomas K Varghese Jr, Cornelia M Ulrich, Daniel R Couriel, Lee CJ, Christopher S Noren, and Paul C LaStayo (06/05/2018). A Clinically-Integrated Physical Therapist Model to Implement Cancer Rehabilitation Best Practices [Abstract].
- Barnes, Christopher, Lee CJ, Rushton, Ryan J, Osborn, James D, Sweetser, Erin, Gaillard, Jeramie, Marcus, Robin L, Noren, Christopher S, LaStayo, Paul, Couriel, Daniel R (2018). Use of a Patient-Reported Physical Function Measure Allows Clinically- Pragmatic, Individually-Tailored Exercise Interventions for People with Chronic Graft- Versus-Host Disease [Abstract].
- Lee CJ, et al (2018). Myeloablative, Intravenous Busulfan-Based Regimen Prior to Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignancies Is Safe and Effective in Patients Age 60 and Older [Abstract]. Biol Blood Marrow Transplant, 24(3(supp1)), S332.
- Lee CJ, et al (2018). Impact of Geographic and Socioeconomic Factors (SEF) on Long-Term Hematopoietic Stem Cell Transplant (HSCT) Outcomes [Abstract]. Biol Blood Marrow Transplant, 24(3(supp1)), S222.
- Barnes, Christopher, Lee CJ, Rushton, Ryan J, Osborn, James D, Sweetser, Erin, Gaillard, Jeramie, Marcus, Robin L, Noren, Christopher S, Couriel, Daniel R, LaStayo, Paul (2018). Assessing and Intervening to Improve Mobility for People with Post-Acute Hematopoietic Cell Transplant: A Quality Improvement Project [Abstract]. Biol Blood Marrow Transplant, 24(3(supp1)), S269.
- Lee CJ, Ariztia EV, Fishman DA (2007). Lysophosphatidic acid (LPA) regulates cell surface expression of e-cadherin in ovarian carcinoma cells; also presented as a poster at 2007 Scientific Annual Meeting of the Society for Gynecologic Investigation 3/14-17/2007, Reno, NV [Abstract]. Reproductive Sciences, 14(1), 173a.
Newspaper
- Lee CJ (2019). Is home-based remote monitoring ready for prime time in oncology? HemOnc today.
Other
- Himbert C, Hathaway CA, Daniels B, Salas K, Ashworth A, Gigic B, Lin T, Viskochil R, Kirchhoff AC, Grossman D, Ose J, Tward J, Scaife C, Figueiredo JC, Toriola AT, Beck A, Shibata D, Gonzalez BD, Matsen C, Christenson C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Schneider M, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM, Peoples AR (2021). Impact of the COVID-19 pandemic on exercise habits among cancer patients. United States.
- Inamoto Y, Petriek I, Burns L, Chhabra S, DeFilipp Z, Hematti P, Rov A, Schears R, Shah A, Agrawal V, Al-Khinji A, Ahmed I, Ali A, Aljurf M, Alkhateeb H, Beitinjaneh A, Bhatt N, Buchbinder D, Byrne M, Callander N, Fahnehjelm K, Farhadfar N, Gale RP, Ganguly S, Hildebrandt GC, Horn E, Jakubowski A, Kamble RT, Law J, Lee C, Nathan S, Penack O, Pingali R, Prasad P, Pulanic D, Rotz S, Shreenivas A, Steinberg A, Tabbara K, Tichelli A, Wirk B, Yared J, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Valds-Sanz N (2019). Correction: Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. Bone Marrow Transplant (54(5), pp. 782-783). England.
Video/Film/CD/Web/Podcast
- Catherine J Lee (2021). Season 6 of Marrow Masters Podcast: All Things Graft vs. Host Disease [Podcast]. nbmtLINK.
- Daniel Kiefer, MD and Ashley Roman, MD, MPH, Lee CJ, acknowledged for manuscript drafting (2007). Management of hematomas incurred as a result of obstetrical deliveries [Web]. UpToDate. Available: http://www.uptodate.com/contents/management-of-hematomas-incurred-as-a-result-of-obstetrical-delivery.
Global Impact
Selected Provider Publications
Journal Article
Lee CJ, Labopin M, Beelen D, Finke J, Blaise D, Ganser A, Itl-Remes M, Chevallier P, Labussire-Wallet H1, Maertens J, Yakoub-Agha I, Bourhis JH, Mailhol A, Mohty M, Savani BN, Nagler A (2018). Comparative outcomes of myeloablative and reduced-intensity conditioning allogeneic hematopoietic cell transplantation for therapy-related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantation. Am J Hematol, 94(4), 431-438.
Global Impact: Global.Yoshihiro Inamoto, Nuria Valds-Sanz, Yoko Ogawa, Monica Alves, Luigi Berchicci, John Galvin, Hildegard Greinix, Gregory Hale, Biljana Horn, Debra Kelly, Hien Liu, Scott Rowley, Helene Schoemans, Ami Shah, Maria Stanghellini, Vaibhav Agrawal, Ibrahim Ahmed, Asim Ali, Neel Bhatt, Michael Byrne, Saurabh Chhabra, Zachariah DeFilipp, Kristina Fahnehjelm, Nosha Farhadfar, Erich Horn, Lee CJ, Sunita Nathan, Olaf Penack, Pinki Prasad, Seth Rotz, Alicia Rov, Jean Yared, Steven Pavletic, Grzegorz Basak, Minnoo Battiwalla, Rafael Duarte, Bipin Savani, Mary Flowers, Bronwen Shaw, and Igor Petricek (12/07/2018). Ocular graft-versus-host disease after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. Biol Blood Marrow Transplant, 25(2), e46-e54.
Global Impact: Global.Yoshihiro Inamoto, Igor Petricek, Linda Burns, Saurabh Chhabra, Zachariah DeFilipp, Peiman Hematti, Alicia Rov, Raquel Schears, Ami Shah, Vaibhav Agrawal, Aisha Al Khinji, Ibrahim Ahmed, Asim Ali, Mahmoud D Aljurf, Hassan Alkhateeb, Amer Beitinjaneh, Neel Bhatt, David Buchbinder, Michael Byrne, Natalie Callander, Kristina Fahnehjelm, Nosha Farhadfar, Robert Gale, Siddhartha Ganguly, Gerhard Hildebrandt, Erich Horn, Ann Jakubowski, Rammurti Kamble, Jason Law, Lee CJ, Sunita Nathan, Olaf Penack, Sai Pingali, Pinki Prasad, Drazen Pulanic, Seth Rotz, Aditya Shreenivas, Amir Steinberg, KF Tabbara, Andr Tichelli, Baldeep Wirk, Jean Yared, Grzegorz Basak, Minnoo Battiwalla, Rafael Duarte, BipinSavani, Mary Flowers, Bronwen Shaw, and Nuria Valds-Sanz (12/07/2018). Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. Bone Marrow Transplant, 54(5), 648-661.
Global Impact: Global.Lee CJ, Savani BN, Mohty M, Gorin NC, Labopin M, Ruggeri A, Schmid C, Baron F, Esteve J, Giebel S, Ciceri F, Nagler A (09/01/2018). Post-remission strategies for the prevention of relapse following allogeneic hematopoietic cell transplantation for high-risk acute myeloid leukemia: Expert review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant, 54(4), 519-530.
Global Impact: Global.Kelly DL, Buchbinder D, Duarte RF, Auletta JJ, Bhatt N, Byrne M, Gabriel M, Mahindra A, Norkin M, Schoemans H, Shah AJ, Ahmed I, Atsuta Y, Basak GW, Beattie S, Bhella S, Bredeson C, Bunin N, Dalal J, Daly A, Gajewski J, Gale RP, Galvin J, Hamadani M, Hayashi RJ, Adekola K, Law J, Lee CJ, Liesveld J, Malone AK, Nagler A, Naik S, Nishihori T, Parsons SK, Scherwath A, Schofield HL, Soiffer R, Szer J, Twist I, Warwick A, Wirk BM, Yi J, Battiwalla M, Flowers ME, Savani B, Shaw BE (2018). Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review From the Late Effects and Quality of Life Working Committee of the CIBMTR and Complications and Quality of Life Working Party of the EBMT. Biol Blood Marrow Transplant, 24(2), 228-241.
Global Impact: Global.
Book Chapter
Nguyen A and Lee CJ (05/28/2018). Immunodeficiency-associated Lymphoproliferative Disorders. In Francis P. Worden, MD, Rami N. Khoriaty, MD, Kathleen A. Cooney, MD, MACP, and Michael W. Deininger, MD, PhD (Eds.), Hematology Board Review: Blueprint Study Guide and Q&A.
Global Impact: Global.
Abstract
Lee CJ, Soyoung Kim, Heather R Tecca, Ruta Brazauskas, Minoo Battiwalla, David K Buchbinder, Mary E D Flowers, Rachel Phelan, Bronwen E Shaw and Lori S Muffly (01/14/2019). Impact of Myeloablative Total Body Irradiation Versus Chemotherapy on Late Effects and Survival Among Adolescent and Young Adult Survivors of Hematopoietic Cell Transplantation for Acute Leukemia: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis [Abstract]. Blood, 132.
Global Impact: Global.Lee CJ, Myriam Labopin, Dietrich Beelen, Jrgen Finke, Didier Blaise, Arnold Ganser, Maija Itl-Remes, Patrice Chevallier, Hlne Labussire-Wallet, MD, PhD, Johan Maertens, Ibrahim Yakoub-Agha, Jean-Henri Bourhis, Audrey Mailhol, Mohamed Mohty, Bipin Savani, Arnon Nagler (12/01/2018). Superior Outcomes With Myeloablative Versus Reduced-Intensity Conditioning Allogeneic Hematopoetic Cell Transplantation for Secondary Acute Myeloid Leukemia with Prior Solid Tumor: An ALWP of EBMT Study [Abstract]. Bone Marrow Transplantation.
Global Impact: Global.Lee CJ, et al (2018). Myeloablative, Intravenous Busulfan-Based Regimen Prior to Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignancies Is Safe and Effective in Patients Age 60 and Older [Abstract]. Biol Blood Marrow Transplant, 24(3(supp1)), S332.
Global Impact: Global.